In the first study to explore the entire human genome for variations that may influence the development of schizophrenia, researchers have discovered two new sites of genetic variation that are closely associated with the disease.  “By implicating two previously unknown…

The latest gene-scanning technology may have shed some much-desired light on a potential cause for schizophrenia, a mental disorder characterized by delusions and scrambled thought processes. The disease is believed to affect 1% of the population.

The pharmaceutical giant, Eli Lilly, is being sued by the state of Alaska over allegedly covering up the potential risks of Zyprexa (olanzapine). Attorneys for the state argue that the company knew that the drug, approved for the treatment of…